Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusagro consolidated 100% of GK Agro-Belogorye

11/13/24 AGRO

Uralsib reported for 9 months of 2024 by RAS

11/13/24 USBN

MGTS reported for 9 months of 2024 by RAS

11/12/24 MGTS

Rostelecom reported for 9 months of 2024 by RAS

11/12/24 RTKM

Fix Price's selling space reached 1.5 mln sq. m.

11/12/24 FIXP

Positive Technologies started placement of additional share issue

11/12/24 POSI

Rostechnadzor lifted the ban on mining operations at Yuzhuralzolot's open pits

11/12/24 UGLD

Aeroflot's passenger traffic in October grew by 14.2%

11/12/24 AFLT

RBC enters the radio market

11/12/24 RBCM

Henderson's revenue in October grew by 10.2%

11/12/24 HNFG